RE:A first: Drug lowers heart risks by curbing inflammationPersonally, this is the main thing that worries me about Ceapro. They will have to compete with large drug companies that make synthetic comparables to fight off inflammation. Most people like to take the easy way out when it comes to their health. Pop a pill vs. working out and eating healthy oats. Seems like Ceapro is placing themselves in the right field, but competition will be stiff in these markets.